Production (Stage)
Monte Rosa Therapeutics, Inc.
GLUE
$5.01
$0.398.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.04% | 60.12% | 35.70% | 29.12% | -16.76% |
| Total Receivables | 134.28% | -65.74% | 102.38% | 752.86% | -72.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.44% | 55.37% | 103.53% | 50.59% | -2.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 66.94% | 59.79% | 37.34% | 33.54% | -17.26% |
|
|
|||||
| Total Current Assets | 66.94% | 59.79% | 37.34% | 33.54% | -17.26% |
| Net Property, Plant & Equipment | -10.98% | -10.06% | -8.69% | -6.93% | -2.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.29% | 0.93% | 5.74% | 5.33% | 12.41% |
| Total Assets | 47.41% | 44.44% | 24.98% | 23.51% | -13.68% |
|
|
|||||
| Total Accounts Payable | -4.96% | 54.37% | -27.67% | 21.95% | -7.50% |
| Total Accrued Expenses | 38.73% | 19.35% | 21.87% | 24.83% | 33.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.55% | 17.46% | 26.55% | 30.15% | 15.74% |
| Total Finance Division Other Current Liabilities | 63.94% | 523.22% | 595.36% | 779.32% | 488.30% |
| Total Other Current Liabilities | 63.94% | 523.22% | 595.36% | 779.32% | 488.30% |
| Total Current Liabilities | 43.40% | 236.85% | 84.18% | 121.85% | 101.28% |
|
|
|||||
| Total Current Liabilities | 43.40% | 236.85% | 84.18% | 121.85% | 101.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.17% | -9.04% | -7.96% | -7.85% | -3.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -33.04% | -43.35% | 1,822.23% | 2,305.98% | 1,956.68% |
| Total Liabilities | 3.34% | 73.32% | 62.21% | 83.87% | 74.92% |
|
|
|||||
| Common Stock & APIC | 21.18% | 21.36% | 27.22% | 27.77% | 8.94% |
| Retained Earnings | 1.55% | -19.87% | -35.89% | -43.80% | -51.52% |
| Treasury Stock & Other | -23.62% | -23.20% | -59.59% | -62.80% | -93.32% |
| Total Common Equity | 80.41% | 24.37% | 11.34% | 5.16% | -37.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 80.41% | 24.37% | 11.34% | 5.16% | -37.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 80.41% | 24.37% | 11.34% | 5.16% | -37.42% |
|
|
|||||